For instance, in our series, IDH sequencing allowed for the re-categorization of a patient with negative IDH R132H IHC and an R172K mutation identified by NGS, moving from a glioblastoma to a grade 4 IDH-mutant astrocytoma. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).